Edesa Biotech, Inc. (EDSA): Wow. What a volume. Got in too and holdi...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Edesa Biotech, Inc. (EDSA)

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	220
Posts	5664
Boards Moderated	0
Alias Born	03/29/2020

Re: None

Thursday, 07/30/2020 3:57:00 PM

Thursday, July 30, 2020 3:57:00 PM

Wow. What a volume. Got in too and holding tight to my shares for tomorrow's extended play.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent EDSA News

Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/03/2026 08:35:25 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/03/2026 08:33:32 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2026 08:31:44 PM
Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit • GlobeNewswire Inc. • 03/31/2026 08:20:00 PM
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment • GlobeNewswire Inc. • 03/26/2026 01:15:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 10:01:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 10:01:11 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:01:45 PM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/03/2026 09:25:15 PM
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/03/2026 12:03:40 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 10:05:59 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 10:01:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2026 02:21:03 PM
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study • GlobeNewswire Inc. • 02/24/2026 02:15:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 09:45:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 09:30:29 PM
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results • GlobeNewswire Inc. • 02/13/2026 09:20:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2026 10:01:02 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 02:00:34 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2025 09:45:26 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/12/2025 09:40:32 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/12/2025 09:30:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2025 09:25:30 PM
Edesa Biotech Reports Fiscal Year 2025 Results • GlobeNewswire Inc. • 12/12/2025 09:20:00 PM

More EDSA News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow